Hologic Non Currrent Assets Other from 2010 to 2025

HOLX Stock  USD 61.32  1.00  1.60%   
Hologic Non Currrent Assets Other yearly trend continues to be fairly stable with very little volatility. Non Currrent Assets Other are likely to outpace its year average in 2025. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
1990-03-31
Previous Quarter
351.4 M
Current Value
433.8 M
Quarterly Volatility
130.2 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 373.1 M, Interest Expense of 74.8 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 2.14, Dividend Yield of 0.0 or PTB Ratio of 3.24. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Non Currrent Assets Other Growth Pattern

Below is the plot of the Non Currrent Assets Other of Hologic over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Hologic's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Non Currrent Assets Other10 Years Trend
Slightly volatile
   Non Currrent Assets Other   
       Timeline  

Hologic Non Currrent Assets Other Regression Statistics

Arithmetic Mean207,488,438
Geometric Mean106,587,434
Coefficient Of Variation81.28
Mean Deviation138,278,797
Median163,902,000
Standard Deviation168,639,605
Sample Variance28439.3T
Range495.9M
R-Value0.79
Mean Square Error11366.5T
R-Squared0.63
Significance0.0003
Slope28,047,172
Total Sum of Squares426589.7T

Hologic Non Currrent Assets Other History

2025496 M
2024472.4 M
2023410.8 M
2022267.9 M
2021188.8 M
2020214.3 M
2019489.7 M

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Currrent Assets Other472.4 M496 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.